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ABSTRACT
Altered functioning of the biological clock is involved in cancer onset and 
progression. MicroRNAs (miRNAs) interact with the clock genes modulating the 
function of genetically encoded molecular clockworks. Collaborative interactions 
may take place within the coding-noncoding RNA regulatory networks. We aimed to 
evaluate the cross-talk among miRNAs and clock genes in colorectal cancer (CRC). 
We performed an integrative analysis of miRNA-miRNA and miRNA-mRNA interactions 
on high-throughput molecular profiling of matched human CRC tissue and non-tumor 
mucosa, pinpointing core clock genes and their targeting miRNAs. Data obtained 
in silico were validated in CRC patients and human colon cancer cell lines. In silico 
we found severe alterations of clock gene–related coding-noncoding RNA regulatory 
networks in tumor tissues, which were later corroborated by the analysis of human 
CRC specimens and experiments performed in vitro. In conclusion, specific miRNAs 
target and regulate the transcription/translation of clock genes and clock gene-related 
miRNA-miRNA as well as mRNA-miRNA interactions are altered in colorectal cancer. 
Exploration of the interplay between specific miRNAs and genes, which are critically 
involved in the functioning of the biological clock, provides a better understanding 
of the importance of the miRNA-clock genes axis and its derangement in colorectal 
cancer.
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INTRODUCTION
Colorectal cancer (CRC) represents the third 
most commonly diagnosed malignancy and the fourth 
leading cause of cancer deaths [1–3]. At present, the only 
therapeutic strategies include surgery and adjuvant or neo-
adjuvant chemotherapy; thus, there is a definite need for 
innovative biological targets for prognostic stratification 
and therapeutic interventions. Colorectal carcinogenesis 
implies alterations of basic cellular processes, such 
as differentiation, proliferation and apoptosis. These 
processes and the overall physiologic functions of living 
beings are characterized by rhythmic oscillations recurring 
with a periodicity of approximately 24 hours (circadian) 
[4–7]. The circadian rhythms are driven by molecular 
clockworks ticking in every cell through transcriptional-
translational feedback loops (TTFLs) revolving in about 
24 hours and operated by circadian genes and proteins 
[8, 9]. TTFLs are initiated by the transcription factors 
BMAL1/2 (ARNTL/ARNTL2) and CLOCK/NPAS2, 
which heterodimerize and activate the transcription of 
PERIOD (PER1-3) and CRYPTOCHROME (CRY1-2) 
genes. In turn, PER and CRY proteins heterodimerize and 
inhibit the transcriptional activity of BMAL1/2 - CLOCK/
NPAS2 heterodimers [10]. BMAL1/2 activates also the 
expression of NR1D1/NR1D2, encoding the transcription 
factors Rev-Erbα/β that, in turn, negatively control the 
rhythmic transcription of BMAL1, hindering RORα 
binding to the response element in the BMAL1 promoter 
region [11]. In the molecular clockwork of Drosophila 
Melanogaster a key role is played by Timeless (Tim) 
[12], and precisely there are two Tim paralogs, Tim1 and 
Tim2 (also called Timeout). Tim1 is a canonical circadian 
component, whereas the role of Tim2 in the fly is presently 
unclear [13]. In mammals the homolog of Tim2 seems to 
be not essential for the ticking of the biological clock, but 
the encoded protein interacts with TIPIN and is crucial 
for replication protection and genomic stability [14], as 
well as for coordination of mitotic kinase activation with 
DNA replication termination [15], period determination 
and DNA damage-dependent phase advancing of the 
circadian clock [16]. The circadian proteins undergo also 
post-translational modifications, such as phosphorylation 
by Casein Kinase 1ε (CK1ε) and AMPK and deacetylation 
by SIRT1, which tag them for degradation or modify their 
functions, respectively [17–20]. 
MicroRNAs (miRNAs) are small, endogenous, 
single-stranded RNAs of 18–22 nucleotides (nt) in 
length that are emerging as important modulators of gene 
expression at post-transcriptional level. They promote 
translational repression and/or destabilization of target 
messenger RNAs (mRNAs) by base-pairing to partially 
complementary sites in the 3ʹ untranslated region (3ʹUTR), 
less frequently in the coding sequences (CDS), of the 
target mRNAs [21]. The same mRNA transcript may be 
targeted by different miRNAs and a single miRNA, in turn, 
may target several different mRNAs [22]. Derangements 
in the miRNA-mRNA interactions [23], as well as altered 
expression of clock genes [24, 25] play a role in CRC onset 
and development and impact colon cancer cell behavior 
and response to chemotherapy [26, 27].
In this study we performed an integrative analysis 
of miRNA-miRNA and miRNA-mRNA interactions using 
high-throughput mRNA and miRNA expression profiling 
of CRC datasets to explore miRNA-clock genes interplays 
searching for functional relationships that are deranged in 
this tumor type. We addressed this aim by investigating the 
miRNA correlation network built on a miRNA expression 
profile database, which was populated with a set of human 
CRC specimens and matched adjacent normal mucosa 
in order to identify the miRNAs that, among those 
targeting the core clock genes, may play a key role in this 
malignancy. These miRNAs populated the subset 1 of this 
analysis. Similarly, we investigated the miRNA correlation 
network built on the miRNA expression profiles obtained 
from the Colon adenocarcinoma (COAD) database 
publicly available on the web through The Cancer Genome 
Atlas (TCGA) Data Portal (https://tcga-data.nci.nih.gov/
tcga/, downloaded March 15th, 2015). These miRNAs 
populated the subset 2 of this analysis. We then compared 
the two correlation networks in terms of connectivity and 
node centrality. Finally, based on the expression levels and 
on topological considerations of miRNAs and clock genes, 
we selected miR-139-5p and TIMELESS to be further 
validated, in vitro, in a new cohort of CRC patients and in 
human colon cancer cell lines.
RESULTS
A priori filtering of miRNA correlation pairs in 
TCGA and colon cancer microarray cohorts
We performed the Pearson Product Moment 
Correlation (PPMC) analysis on our CRC dataset 
(Table 1) and one publicly available dataset: miRNAs 
making significant pairs were counted and the numbers 
obtained were compared. The miRNAs detected in the 
COAD-TCGA dataset and present or not in our arrays 
were reported. Notably, COAD-TCGA control and tumor 
samples shared 501 miRNAs, while all miRNAs in control 
samples were shared with tumor samples. Moreover, 
among these latter samples, half of individual miRNAs 
were common to both datasets. The numbers of miRNAs 
that were exclusively correlated in control rather than in 
tumor samples were almost balanced in the microarray 
dataset (Supplementary Tables S1–S5).
Identification of common or unique miRNA 
pairs through different conditions
Weak correlations were excluded by considering 
only miRNA pairs with an r exceeding ± 0.8. Thus, 
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1 PS1 58 Female PTRCF Yes G2 II T3N0M0
2 PS3 81 Male PTRCF Yes G1 I T2N0M0
3 PS4 61 Male Sigmoid Yes G2 III T3N1M0
4 PS5 69 Female DTLCF Yes G1 IV T4N2M1
5 PS7 77 Male Sigmoid Yes G2 I T2N0M0
6 PS10 67 Male Sigmoid Yes G2 III T3N2M0
7 PS11 67 Male Sigmoid Yes G1 III T3N1M0
8 PS12 57 Male Sigmoid Yes G2 II T3N0M0
9 PS13 81 Female Sigmoid Yes G1 II T3N0M0
10 PS14 81 Female Rectosigmoid Yes G2 I T2N0M0
11 PS15 77 Male DTLCF Yes G2 III T3N1M0
12 PS17 73 Female Coecum Yes G3 III T3N1M0
13 PS19 57 Male Sigmoid Yes G2 II T3N0M0
14 PS20 55 Male Descendens Yes G1 II T3N0M0
Abbreviations: PTRCF = Proximal transverse and right colic flexure; DTLCF = Distal transverse and left colic flexure TNM 
(classification of malignant tumors): T, size or direct extent of the primary tumor; N, degree of spread to regional lymph 
nodes; M, presence of distant metastasis.
Figure 1: Venn-Diagrams of the shared miRNA-miRNA correlation pairs. Venn-Diagram of the shared miRNA-miRNA 
correlation pairs in the microarray (A) and the COAD-TCGA (B) datasets that are exclusive to tumor tissue (left), exclusive to non-tumor 
tissue (right) or common between the two tissue types (overlapping). (Filtering criteria: Pearson Product Moment Correlation score ± 
0.6, absolute value, and p ≤ 0.05); (C) Venn-Diagram of the shared miRNA-miRNA correlation pairs in the microarray dataset. (Filtering 
criteria: Pearson Product Moment Correlation score ± 0.8, absolute value, and p ≤ 0.05).
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the remaining pairs of miRNAs in tumor and control 
networks were compared to discover those peculiar for 
each disease condition. Figure 1A shows the intersections 
of these miRNA correlation pairs in the microarray 
dataset. It is worthy of note that the COAD-TCGA dataset 
(Figure 1B) is unbalanced in terms of number of tumor 
correlation pairs with respect to the number of control 
correlation pairs. Roughly, 10% of pairs are in common 
with the control ones in both datasets (Figure 1C). 
MiRNAs targeting clock genes were searched in both 
subsets with the main goal to define whether these 
miRNA groups had some elements in common. Indeed, 
a significant percentage of them was present in each 
subset and a further interesting part correlated (i.e., there 
were correlation pairs between miRNAs targeting clock 
genes). This finding likely indicates that pairs of correlated 
miRNAs may cooperate to target the core clock genes. 
Moreover, the strongly correlated miRNAs set was bigger 
in control than tumor samples, underscoring, on one hand, 
the important regulatory role of miRNAs in normal tissue 
and, on the other hand, that deregulation of almost one 
third of them may play a critical role in CRC development.
Candidate miRNAs involved in clock genes 
deregulation in colorectal cancer
We drew and analyzed the networks of the following 
subsets: the common subset, the correlation subset 
exclusive for the correlation pairs in non-tumor tissue 
(control subset) and the correlation subset exclusive for 
the correlation pairs in neoplastic tissue (tumor subset). 
The visual representation of these networks is rendered 
in Figure 2. From a preliminary survey, it can be noticed 
that the common subset miRNAs generate a highly sparse 
correlation network and tend to form closed and unrelated 
clusters (Figure 2A). miR-20a-5p, the miRNA with the 
highest betweeness centrality value (0.667), reaches the 
maximum degree in this network that is 3. It is important 
to consider that, in this network, many miRNAs are also 
differentially expressed without a significant link between 
the fold-change and the r value. Moreover, many miRNAs 
targeting clock genes did not come out from the COAD-
TCGA dataset analysis.
Analysis of the miRNA network built on the 
control subset verified a strong correlation among the 
vast majority of the nodes, with only a few tending to 
form small isolated clusters (Figure 2B). Several positive 
correlations were present in the core network, many of 
which did not appear in the COAD-TCGA dataset. The 
node with the smallest average shortest path length is 
miR-34a-5p that targets CRY1, a core element of the 
molecular clockwork. This miRNA came out from the 
analysis of the COAD-TCGA dataset and displayed the 
highest degree centrality and the lowest average shortest 
path length together with a relatively low clustering 
coefficient. However, the expression of this miRNA did 
not significantly change between tumor and non-tumor 
tissues. On its side, the miRNA network built on the tumor 
subset displayed some interesting properties (Figure 2C). 
Apart from isolated correlation pairs, it showed an intricate 
correlation network and the node with the highest degree 
was let-7e-5p that was only slightly down-regulated in 
tumor tissue. This miRNA, belonging to the let family and 
involved in stemness, showed also a good centrality value 
(around 0.4), pointing it as a hub in our tumor correlation 
network. Moreover, this node was positively correlated 
with a series of other miRNAs hallmarked by low-fold 
change values, implying that their deregulation might 
trigger the reduced expression of several other miRNAs. 
Additionally, the fold-change and the correlation values 
indicated miR-19-3b as a possible negative regulator of 
the let-7-e-5p gene, as it was negatively correlated and 
up-regulated in tumor. miR-19b-3p targets TIMELESS 
and NR1D2 and many of its correlated neighbours, let-
7e-5p, miR-99b-5p and, indirectly, miR-140-3p (separated 
by 1 degree and connected via miR-214-3p and miR-212-
3p) are instead down-regulated, suggesting a potential 
regulation of miR-19b-3p on these miRNAs. 
As illustrated in Table 2 and Figure 3, miR-125b-
5p, miR-140-3p, let-7e-5p and miR-99b-5p are all down-
regulated in tumor as compared to non-tumor tissues and 
all target clock genes. Noteworthy, miR-19b-3p is weakly 
(−0.47) anti-correlated with miR-99b-5p in the control 
subset, but the anti-correlation strength becomes stronger 
in the tumor subset. Besides, these miRNAs are involved 
in the pathways controlling cancer cell proliferation and 
invasiveness (Supplementary Table S6)
In the control network, let-7e-5p is linked to 
miR-139-5p, a candidate tumor suppressor targeting 
TIMELESS and found down-regulated in many cancer 
types, but in the tumor network this important link was 
lost. Interestingly, as reported in Supplementary Table S3, 
miR-139-5p was down-regulated and ranked among 
the most deregulated miRNAs in tumor tissues (False 
Discovery Rate = 0.002668, Fold Change = −6.801375, 
p value = 0.000013). miR-139-5p recognizes two seed 
regions in TIMELESS mRNA and we decided to select this 
miRNA/gene pair for validation in an independent cohort 
of patients and, then, for in vitro functional studies. 
TIMELESS mRNA and miR139-5p levels  
are altered and inversely correlated in  
sporadic CRCs
We quantified TIMELESS mRNA and miR-139-5p 
levels in 50 matched pairs of tumor tissues/non-tumor 
mucosa sampled from 46 well-moderately differentiated 
(G1-G2) and from 4 poorly differentiated-undifferentiated 
(G3-G4) CRCs. Median values, 25th (or first quartile, Q1) 
and 75th percentile (or third quartile, Q3) of GAPDH-
Ct value/target gene-Ct value are shown in Figure 4. 
Compared to matched non-tumor tissues a statistically 
significant increase of TIMELESS mRNA (median = 1.25, 
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Q1-Q3 = 0.87-2.13, p < 0.001) and a decrease of miR-139-
5p levels (median = 0.15, Q1–Q3 = 0.06–0.44, p < 0.0001) 
was observed in tumor tissues. TIMELESS mRNA was 
inversely correlated with miR-139-5p expression by a 
Pearson’s correlation test (r = −0.320; p = 0.027) (Figure 4 
upper panel). These results were corroborated by the 
analysis of an independent publicly available COAD-
TGCA cohort comprising 210 CRC samples for which 
mRNA and miRNA expression profile were attainable 
(https://tcga-data.nci.nih.gov/tcga) (r = −0.160; p = 0.021) 
(Figure 4 lower panel).
Clinical-pathological features of CRC patients 
and association with TIMELESS mRNA and 
miR-139-5p levels 
Genotype-phenotype associations were evaluated 
in our validation cohort of CRC patients. After splitting 
subjects at the median value of gene expression levels, 
the increased TIMELESS mRNA level in tumor tissue was 
strongly associated with disease spreading, in particular 
with proximal and distal lymph nodes involvement 
(p = 0.010) and III-IV TNM stages (p = 0.017). Lower 
miR-139-5p levels were associated with a non-mucinous 
adenocarcinoma histologic type (p = 0.035) and high 
microsatellite instability frequency (p = 0.035) (Table 3). 
No statistically significant difference was found 
for survival rates in a Kaplan–Meier analysis of censored 
data after stratifying patients according to the median 
expression value of TIMELESS mRNA (Log Rank–
Mantel-Cox test p = 0.721) and miR139-5p (Log Rank-
Mantel-Cox test p = 0.515) (Supplementary Figure S1).
TIMELESS and miR-139-5p levels are inversely 
related in human colon cancer cell lines 
TIMELESS expression at the mRNA and protein 
levels was evaluated in CaCo2, HCT116, HT29, SW480 
and SW620 cells: TIMELESS mRNA expression was 
higher in tumor than non-tumor mucosa and mainly in 
Figure 2: Network picture of colorectal cancer miRNA-ome datasets based on Pearson Product Moment Correlation 
network of commonly correlated miRNAs in tumor and non-tumor tissue. (A) Network representation of the common 
miRNA correlation pairs among neoplastic (tumor) and matched non-tumor tissue (control). (B) Network visual representation of the 
miRNA correlation pairs specific for the control tissue. (C) Network visual representation of the miRNA correlation pairs specific for the 
tumor tissue. Nodes represent miRNAs that are linked by an edge if their expression values correlate (red for positive correlations, green 
otherwise). Shapes and colours represent features of nodes and edges. Red nodes render up-regulated miRNAs in tumor; green nodes render 
down-regulated miRNAs in tumor. Bold node render miRNAs that are experimentally known to target any core clock gene. Triangle-shaped 
nodes render miRNAs whose expression values are cross-checked in the TCGA-COAD dataset.
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CaCo2 and HT29 cells with respect to HCT116, SW480 
and SW620 cells (Figure 5A). Western blot analysis on 
extracts from the same cells showed higher levels of the 
protein in CaCo2, HCT116 and in particular SW620 cells, 
suggesting a key role played by miR-139-5p in TIMELESS 
post-transcriptional regulation (Figure 5B). Indeed, 
miR-139-5p expression displayed an opposite pattern 
to TIMELESS, with lower levels in all the examined 
cell lines than non-tumor mucosa; lower levels were 
detected in CaCo2 and HT29 with respect to HCT116, 
SW480 and SW620 cells (Figure 5A). Bioinformatic 
analysis identified two seed regions for miR-139-5p in 
the CDS and 3ʹUTR of TIMELESS mRNA, respectively 
(Figure 5C). Thus, we investigated the miR-139-5p-
dependent TIMELESS regulation in vitro. Modulation of 
miR-139-5p expression through mimic or antisense RNAs 
induced remarkable and inverse variations of TIMELESS 
in CRC cells. In detail, miR-139-5p inhibition resulted 
in TIMELESS overexpression in HCT116 and HT29 
with respect to SW480 and SW620, while no statistically 
significant variation was observed in CaCo2 cells. In 
contrast, transfection of a miR-139-5p mimic down-
regulated TIMELESS in all cells lines under investigation 
(Figure 5D). These data confirm that miR-139-5p 
inversely correlates with TIMELESS regulating its protein 
levels in human colon cancer cells. 
Table 2: List of the clock genes targets of the most relevant correlated miRNAs 
Fold Change (Tumor versus Control) Targets
let-7e-5p Down PER1, CLOCK
miR-125b-5p Down PER1, RORA, TIPIN
miR-140-3p Down NPAS2, TIMELESS
miR-99b-5p Down PER1, RORA, TIMELESS
miR-19b-3p Up TIMELESS, NR1D2
miR-139-5p Down TIMELESS 
Figure 3: Core clock genes-miRNAs correlation network in colorectal cancer. Multi-layer network of clock genes and 
targeting miRNAs in which nodes represent clock genes or miRNAs, while edges represent correlation or interaction among miRNAs or 
genes. Nodes representing genes are bigger than miRNA nodes. miRNA names are bolded if any association with clock genes is known. 
miRNA nodes are represented as triangles if their expression values are consistent in the COAD-TCGA dataset. Red nodes are up-regulated 
genes/miRNAs in tumor tissue, green nodes are down-regulated genes/miRNAs in tumor tissue. Edges between genes are solid or dashed, 
depending on whether they represent direct or indirect interactions, as reported in BioGRID. Edges connecting miRNAs-genes render 
targeting interactions as from miRWalk 2.0. Arrowed edges connecting two miRNAs represent strong positive (> 0.8) or negative (≤ 0.8) 
correlations between them, and are colored in red or green, respectively. 
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FISH comparative analysis of TIMELESS copy 
numbers in human colon cancer cell lines
We hypothesized that the different TIMELESS levels 
found in the colon cancer cell lines could be related to the 
occurrence of copy number gains involving the encoding 
gene. To address this issue, FISH co-hybridization 
experiments were performed in all five colorectal cancer 
cell lines by using a probe set encompassing the whole 
gene region. The overall results showed low copy number 
gains of TIMELESS in all cell lines except HCT116, 
showing signals only on the two normal chromosome 12 
homologs (Figure 6B). Specifically, HT29 displayed a 
whole-chromosome 12 trisomy (Figure 6D); in SW480, 
two markers showed positivity for all the three probes, 
as well as one normal chromosome 12 (Figure 6C); 
CaCo2, in addition to trisomy 12, showed positivity for 
a marker chromosome of unknown origin (Figure 6E). 
Finally, SW620 cells showed the most complex karyotype, 
displaying multiple signals to be ascribed to a whole 
chromosome 12 tetrasomy and two marker chromosomes 
positive for TIMELESS signals (Figure 6F). 
miR-139-5p regulates proliferation, migration, 
colony forming efficiency and apoptosis in 
human colon cancer cell lines 
A potential impact of TIMELESS expression 
changes on cancer cell phenotype modifications was 
suggested by data coming from the analysis of CRC patient 
specimens. To investigate this possibility we assessed the 
effects of TIMELESS down-regulation upon miR-139-
5p ectopic expression on colon cancer cell proliferation, 
apoptosis, migration and colony forming efficiency. Cell 
proliferation was evaluated by automatic cell counting at 
different time points (24, 48 and 72 hrs) from transfection. 
A time-dependent reduction of proliferation was observed 
in all cell lines upon miR-139-5p mimic transfection 
(p < 0.05); the reduction trend was less evident in HT29 
cells (Figure 7A). In contrast, due to the low basal miR-
139-5p levels in all cell lines, a miR-139-5p antisense 
increased the proliferation rate only in HT29 cells 
(p < 0.05). Consistently, miR-139-5p overexpression 
or inhibition induced higher or lower pre-apoptosis and 
apoptosis than basal cells, respectively (Figure 7B). 
Figure 4: TIMELESS mRNA and miR-139-5p levels are inversely correlated in sporadic colorectal cancer. Box-plot 
analysis of TIMELESS mRNA and miR-139-5p levels in our colorectal cancer (CRC) patients validation cohort (upper panel) and in the 
COAD-TCGA dataset (lower panel); p value and r coefficient of correlation are reported in the panels.
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Colony forming efficiency and migration assays were 
severely reduced in all CRC cell lines examined (p < 0.05 
and p < 0.01) upon miR139-5p mimic ectopic expression. 
In contrast, the miR-139-5p antisense induced higher 
migration in HT29 and SW480 cells and, in these latter 
ones, also larger colonies (Figure 8A and 8B). 
DISCUSSION
The definition of higher-order mRNA-miRNA 
interaction networks allows tumor microarray data 
interpretation and hypothesis generation. This, in turn, may 
help in discovering biological pathways deregulated in 
Table 3: Association of TIMELESS mRNA and miR-139.5p levels with clinical and pathological 
features of colorectal cancer patients included in the validation cohort
TIMELESS miR139.5p












< 62 16 1.199 1.061 3.695 0.457 0.122 0.052 0.287 0.360
62–74 19 1.438 0.606 1.939 0.152 0.091 1.268
> 74 15 1.219 0.866 1.796 0.181 0.042 0.408
Gender Male 34 1.353 0.974 2.218 0.546 0.224 0.088 0.727 0.050
Female 16 1.126 0.730 1.927 0.110 0.039 0.195
Tumor location Proximal colon † 17 1.163 0.713 1.916 0.419 0.223 0.098 0.755 0.585
Transverse colon 6 1.247 0.545 1.584 0.157 0.049 0.391
Distal
colon ‡
27 1.267 0.974 2.324 9 0.121 0.057 0.444
Grading G1/G2 45 1.267 0.866 2.218 0.683 0.181 0.056 0.679 0.706
G3/G4 5 1.163 1.119 1.572 0.132 0.098 0.152
Modified Dukes 
Staging System
A 4 1.308 0.977 1.585 0.167 0.047 0.003 0.239 0.265
B 20 0.989 0.564 1.699 0.202 0.068 1.096
C 24 1.714 1.127 2.981 0.166 0.085 0.495
D 2 1.396 1.219 1.572 0.092 0.053 0.132
Histologic Type 
adeno carcinoma
Mucinous 5 1.854 1.063 1.939 0.615 0.727 0.224 0.943 0.035




missing 8 0.381 0.035
High 9 1.543 1.159 1.916 0.053 0.040 0.098
Low 10 1.556 1.163 2.129 0.219 0.111 0.416
Stable 19 1.235 0.974 1.939 0.209 0.056 0.943
LOH 4 0.789 0.432 2.127 0.574 0.203 1.125
Depth of tumor 
invasion
T2 4 1.308 0.977 1.585 0.543 0.047 0.003 0.239 0.225
T3 43 1.267 0.747 2.324 0.181 0.057 0.679
T4 3 1.119 0.074 1.572 0.132 0.079 1.326
Lymph node 
involvement
N0 24 0.989 0.594 1.564 0.010 0.132 0.041 0.684 0.543
N1 14 1.535 1.119 1.939 0.166 0.098 0.755
N2 12 2.613 1.243 3.695 0.170 0.054 0.240
TNM stage I-II 27 1.004 0.582 1.584 0.017 0.151 0.079 0.312 0.899
III-IV 23 1.632 1.135 2.590 0.152 0.042 0.924
Vascular invasion Not 27 1.159 0.636 1.939 0.365 0.181 0.057 0.679 0.992
Yes 23 1.267 1.063 3.371 0.140 0.056 0.391
†caecum and ascending colon; ‡ descending colon, sigmoid colon and rectum; LOH = loss of heterozigosity; N0 = no lymph 
node involvement N1 = proximal lymph node involvement; N2 = distal lymph node involvement; TNM (classification of 
malignant tumors): T, size or direct extent of the primary tumor; N, degree of spread to regional lymph nodes; M, presence 
of distant metastasis.
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tumorigenesis and their possible roles in cancer onset and 
progression [28]. This method of analysis takes advantage 
of network-based models and, in the present study, was 
conducted pinpointing core clock genes and their targeting 
miRNAs. The data from our series of tumor and matched 
non-tumor tissues of CRC patients were validated with 
those obtained from high-throughput publicly available 
molecular profiling of matched colorectal tumor and non-
tumor specimens.
MiRNAs play an important role in gene regulatory 
mechanisms negatively modulating gene expression at 
the post-transcriptional level. Approximately 30% of 
all mRNAs in mammals are regulated by miRNAs [29] 
and recognition occurs via base-pairing interactions with 
seed motifs located in the CDS or the 3ʹ-UTR of target 
mRNAs. Generally, a given miRNA is expected to fine-
tune a large set of mRNAs within a cell [30]. Consistently, 
miRNAs have been implicated in the control of genes 
driving proliferation, development, and differentiation [31]. 
Besides, miRNA expression is regulated in a 
circadian pattern in living beings starting from 
D. melanogaster [32] and miRNAs, in turn, modulate the 
biological clock [33, 34].
Interestingly, our analysis in CRC tissues shows 
a profound subversion of the appropriate relationships 
among miRNAs with respect to those detected in non-
tumor tissue, with loss of connections with the main 
nodes and acquisition of abnormal ones with new partners 
that acquire key roles in the network. Among miRNAs 
regulating clock genes, miR-34a-5p is particularly 
important as it targets CRY1 and has recently been 
identified as a valuable prognostic biomarker in CRC. It 
is, in fact, down-regulated in tumor tissues and positively 
correlated with disease-free survival; it is able to hinder 
Figure 5: miR-139-5p negatively regulates TIMELESS expression in human colon cancer cell lines. (A) The bar plot 
reports miR-139-5p and TIMELESS mRNA levels evaluated by qRT-PCR analysis in the indicated cell lines with respect to the average 
expression detected in non-tumor tissues. (B) Immunoblot detection of TIMELESS protein in five human colon cancer cell lines; relative 
fold-change, obtained by densitometric analysis and normalization to β-actin, is reported in the corresponding histograms. (C) Schematic 
representation of human TIMELESS mRNA: two specific highly conserved miR-139-5p binding sites are located in the coding region 
(CDS; RNA22 prediction) and in 3′ UTR (RNAhybrid prediction). (D) Western blot analysis of TIMELESS in cells transfected with a 
miR-139-5p mimic or inhibitor, or scrambled controls; the histogram reports the protein fold-change with respect to scrambled-transfected 
cells. Samples were analyzed in triplicate and data are reported as mean ± S.D. and representative of three independent experiments. 
*p ≤ 0.05; **p ≤ 0.01.
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CRC recurrence, restraining cell growth, migration and 
invasion, triggering cell apoptosis and cell cycle arrest 
in a p53-dependent manner [35]. In the non-tumor tissue 
network, miR-34a-5p shows the highest degree centrality 
as well as the lowest average shortest path length with 
a relatively low clustering coefficient, while in the 
tumor network it looses the hub function that is acquired 
by let-7e-5p. 
This latter miRNA is implicated in colorectal 
carcinogenesis [36] and targets PER1 and CLOCK 
mRNAs and in our analysis it gains a link to miR-19b-
3p, which targets TIMELESS and NR1D2 mRNAs. It is 
included in the paralogous miRNA gene cluster originating 
the miR-17 family miRNAs (miR-17~92, miR-106a~363 
and miR-106b ~ 25) involved in the control of cell cycle, 
proliferation, apoptosis, development and referred to as 
“oncomir” as frequently deregulated in hematopoietic 
and solid cancers [37, 38]. Finally let-7e-5p lost the link 
with miR-139-5p, an important tumor suppressor found 
deregulated in different cancer types [39–43]. 
miR-19b-3p is correlated with miR-99b-5p, targeting 
PER1, RORA and TIMELESS mRNAs and, indirectly, with 
miR-140-3p, targeting NPAS2 and TIMELESS mRNAs. 
Furthermore, bioinformatic analysis identified miR-139-5p 
seed regions in the CDS and 3ʹUTR of TIMELESS mRNA, 
which plays a key role in DNA damage response, telomere 
length and integrity maintenance, cell cycle progression as 
well as processes coordinated at the DNA replication fork 
Figure 6: Comparative analysis of TIMELESS copy numbers performed by FISH in human colon cancer cell lines. (A) 
The BAC probe set used for the screening of TIMELESS copy number gains. The colored rectangles (blue, red, and green) correspond to 
the FISH results obtained respectively for probes RP11-348M3, RP11-243C3, and RP11-888B6. Genes are reported in blue at the bottom 
of the figure. (B–F) FISH analysis results. In HCT116 the three probes gave signals on the two normal chromosome 12 homologs (B); 
in SW480, two markers showed positivity for all the probes used, as well as one normal chromosome 12 (C); HT29  displayed a whole 
chromosome 12 trisomy (D); CACO2 showed the positivity of a marker chromosome of unknown origin, in addition to chromosome 12 
trisomy (E); SW620 displayed a whole-chromosome 12 tetrasomy and the positivity of two additional marker chromosomes (F).
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such as DNA synthesis, S-phase-dependent checkpoint 
activation and chromosome cohesion [44–47]. 
The potential relationship between TIMELESS 
and miR-139-5p was validated in our cohort of sporadic 
CRC patients, confirming the inverse expression pattern 
and suggesting that deregulation of this axis may play a 
role in disease progression. This was further corroborated 
in a series of human colon cancer cell lines in which 
miR-139-5p induced TIMELESS down-modulation, 
determining the cell phenotype. In fact, restoration of 
miR-139-5p significantly inhibited cell proliferation and 
apoptosis as evidenced by cell count and FACS analysis. 
In contrast, re-expression of miR-139-5p in in vitro assays 
inhibited cell migration in all five cell lines examined.
In conclusion, miRNA-miRNA interactions add 
complexity to the functionality and enhance the robustness 
of coding/noncoding RNA regulatory networks. Alteration 
of this multifaceted interaction plays a crucial role 
in carcinogenesis. Our integrative analysis of the miRNA-
mRNA interplay as well as of the expression patterns of 
Figure 7: miR-139-5p inhibits cell proliferation and apoptosis in human colon cancer cells lines. (A) Graphical representation 
of cell numbers assessed by automatic cell counting at different time points (24, 48 and 72 hrs) from transfection with the miR-139-5p 
mimic, miR-139-5p inhibitor, or the appropriate scrambled controls. (B) Flow cytometry analysis of pre-apoptotic and apoptotic cells 
(Caco-2, SW480 and SW620) transfected with the miR-139-5p mimic, inhibitor or the appropriate scrambled controls. One representative 
experiment out of three is shown. Samples were analyzed in triplicate and data are reported as mean ± S.D. and representative of three 
independent experiments; *p ≤ 0.05; **p ≤ 0.01.
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potential miRNA-miRNA pairs based on the expression 
profiles in CRC tissues and matched adjacent non-tumor 
mucosa underscores the pivotal role that the miRNA-clock 
genes axis plays in colorectal tumorigenesis and improves 
our understanding of the miRNA-mRNA regulatory 
networks deregulated in this common malignancy. 
MATERIALS AND METHODS
Microarray data (subset 1)
The transcriptome and miRNAome of 14 pairs of 
matched tumor tissues and adjacent non-tumor mucosa 
obtained at surgery from CRC patients was analyzed by 
using the GeneChip Human Exon 1.0 ST array and the 
GeneChip miRNA 2.0 array (Affymetrix, Santa Clara, 
CA, USA), respectively [48, 49]. The clinical-pathological 
characteristics of the patients investigated in the current 
study are listed in Table 1.
COAD-TCGA data (subset 2)
Expression profiles of COAD and healthy tissues 
were downloaded from the TCGA data portal, as 
preprocessed and normalized probeset intensity values 
(level 3 data). 
Selection of miRNAs targeting clock genes and 
miRNA symbols disambiguation
We picked up specific experimentally validated 
miRNAs targeting the core clock genes by the miRWalk 
2.0 web service [50]. Several miRNA symbols in both the 
microarray and TCGA data resulted to be not updated and 
thus, for these, it was not possible to distinguish between 
the 5p from the 3p forms. We have then disambiguated 
and updated these symbols by a custom Python script 
operating on the latest CDF file of the miRNA 1.0 chip 
and on the list of miRNA aliases available through the 
miRBase web site. The only two miRNAs, i.e. miR-378 
and miR-34b, which were not possible to disambiguate 
were kept with their original names.
Subset and miRNA-Gene target analyses
The expression values of two miRNAs were 
considered coherently correlated in the tumor and normal 
networks if their r values were significant and both were 
either positive or negative. Any miRNA pair was tagged 
as clock-controller if at least one miRNA of the pair 
controlled one or more clock genes. MiRNAs were further 
highlighted according to their differential expression, 
when compared to control tissues. 
Network analysis
Networks were drawn and analyzed by Cytoscape 
ver. 3.2.1 (http://www.cytoscape.org/). Nodes represent 
miRNAs and edges represent significant correlations 
between two miRNAs. Attributes were added to the nodes 
and edges according to the following features. Nodes 
were colored according to their fold-changes: red for up-
regulated miRNAs, green for down-regulated miRNAs 
and white for miRNAs with no significant or missing 
fold-change values. Moreover, shapes of nodes were 
Figure 8: miR-139-5p reduces the colony forming area and cell invasion in human colon cancer cells lines. (A) Plate 
colony-forming assay performed in the indicated cell lines transfected with miR-139-5p mimic or inhibitor or relative miRNA controls 
and stained with crystal violet (left panel); the histogram reports the value of colonies areas (right panel). (B) Number of invading cells 
measured in at least five fields of the trans-well migration assay in all five human colon cancer cell lines transfected as in (A). Data are 
reported as mean ± SD of at least four independent experiments; *p ≤ 0.05; **p ≤ 0.01. 
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thought to represent the co-occurrence of a miRNA in our 
microarray data (rounded nodes) or in the COAD-TCGA 
data (triangular nodes). Moreover, miRNAs targeting 
clock genes were marked with bold labels. Edges were 
colored according to their correlation levels: red for 
positive correlations and green for negative correlations. 
For each node, we calculated the following topological 
indices: Degree, Closeness, Centrality, Betweeness, 
Clustering Coefficient, Radiality and Average Shortest 
Path Length, as already explained elsewhere [51, 52]. In 
Figure 7 bigger sized nodes represented clock genes, while 
correlated miRNAs were linked with dashed edges.
Validation cohort of CRC patients
The expression levels of TIMELESS mRNA and 
miR-139-5p were evaluated in the tumor tissues and 
adjacent non-tumor mucosa of an independent cohort of 
50 CRC patients (34 men and 16 women, mean age ± SD 
67.2 ± 11.6 years), surgically treated for colon and rectum 
primary tumors at our Hospital. The study was approved 
by the Ethical Board of our Institute, and all patients gave 
written informed consent. Patient characteristics are shown 
in Table 3. All tumor and non-tumor tissue specimens 
were collected between 9:00 a.m. and 17:00 p.m. 
of the same day (8 h), dissected immediately and snap-
frozen in liquid nitrogen. All tissue samples were derived 
from surgical specimens. The frozen sections were 
evaluated by the pathologist to confirm the diagnosis of 
both tumor and non-tumor tissue. The non-tumor mucosa 
was collected in a part of the bowel close to the resection 
margins. The first and the last section of each sample were 
stained with haematoxylin and eosin and were analyzed 
by the pathologist to evaluate the tumor cell percentage. 
Tissue samples having at least 80% of tumor cell content 
were frozen in liquid nitrogen until the molecular analysis. 
These data were corroborated by the examination of 
TIMELESS and miR-139-5p expressions values of COAD 
and healthy tissues downloaded from the TCGA data 
portal, as preprocessed and normalized probeset intensity 
values (level 3).
RNA extraction from freshly frozen tissue and 
colon cancer cell lines and first-strand cDNA 
synthesis
Preparation of total RNA from about 150–200 mg 
of freshly frozen tissue specimens was done using the 
TRIzol reagent (Invitrogen Corporation, Carlsbad, CA, 
USA). The amount of total extracted RNA was determined 
by using the Nano Drop Spectrophotometer (Nanodrop 
Technology,Wilmington, DE, USA), and RNA integrity 
was assessed using Agilent 2100 Bioanalyzer (Agilent 
Technologies, Santa Clara, CA, USA) after subsequent 
digestion by DNaseI. Next, 1.0 µg of total RNA was 
reversed transcribed using the High-Capacity cDNA 
Archive Kit following the manufacturer’s instructions 
(Applied Biosystems, Applera, Foster City, CA, USA).
Quantitative Real-Time reverse transcription-
PCR assay 
Quantitative real-time PCR (qRT-PCR) assay was 
used to assess the differential expression of the TIMELESS 
gene and miR-139-5p in CRC specimens matched to 
normal mucosa. Human QuantiTect Primers Assay (SYBR 
Green QuantiTect Primers Assay; QIAGEN, Hamburg, 
Germany) was used for TIMELESS (QT00019789) and 
qRT-PCRs were performed in a 25-µl final volume, in three 
replicates per sample, by using QuantiFast SYBR Green 
PCR kit (QIAGEN, Hamburg, Germany) and run in an 
ABI PRISM® 7700 Sequence Detection System (Applied 
Biosystems, Applera, Foster City, CA, USA) according to 
the following conditions: 50°C for 2 min, 95°C for 10 min, 
and 40 cycles at 95°C for 15 s and at 60°C for 1 min. Data 
were acquired as threshold cycle (CT) value. Expression 
levels of target gene were normalized using the GAPDH 
housekeeping control gene and the relative amount of 
mRNA in each target gene to GAPDH was calculated 
as the average 2−DDCT method. Since the amplification 
efficiencies of target genes and internal control were 
equal, the relative change of target gene expression in 
tumor cells compared with normal colon mucosa (ΔCt 
calibrator value) was calculated using the equation 2−ΔΔCt, 
where ΔΔCt = ΔCt(calibrator) 
−ΔCt(target). The ΔCt values were 
defined by subtracting the average GAPDH Ct value from 
the average target gene Ct value. The SD of the difference 
was calculated from the SDs of target gene and GAPDH 
values. After each qRT-PCR, a melting profile as well as 
agarose gel electrophoresis of each sample was done to 
rule out nonspecific PCR products and primer dimers. For 
miRNA detection, 10 ng of RNA were reverse transcribed 
using the Taq-Man miRNA reverse transcription kit, 
including miR-139-5p (Assay ID: 478312_mir) and 
endogenous control RNU6B (Assay ID: 001093) primers 
in the reaction. Reverse transcription was followed by 
qRT-PCR assay with a TaqMan PCR Universal master 
mix and the appropriate miRNA specific TaqMan probe 
(Life Technologies Corporation). Expression levels of 
miR-139-5p were normalized to RNU6B and relative 
expression levels were calculated within each independent 
experiment using the formula 2−ΔΔCT. 
Microsatellite instability 
The Microsatellite instability (MSI) analysis was 
performed using the Bethesda panel of microsatellite 
(BAT25, BAT26, D5S346, D17S250 and D2S123) 
evaluated by means of a multiplex-PCR and PAGE 
analysis. Tumors showing instability in four or more 
markers were classified as high MSI (MSI-H), those 
showing instability in two markers as low MSI (MSI-L), 
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and those showing no instability as microsatellite-stable 
(MSS).
Cell culture 
CaCo2, HCT116, HT29, SW480 and SW620 
cells were acquired from ATCC (American Type Cell 
Culture) and cultured as appropriate at 37°C in 5% CO2 
atmosphere in Dulbecco’s modified Eagle’s medium 
(DMEM) and Minimum Essential Medium (MEM) 
Alpha media, supplemented with 10% fetal bovine serum 
(FBS), 100 U/ml penicillin and 100 ng/ml streptomycin 
(Invitrogen Life Technologies, Milan Italy). 
Immunoblot detection 
CaCo2, HCT116, HT 29, SW480 and SW620 cells 
were lysed in a 2× Laemmli Sample buffer [250 mM 
Tris-HCl, pH 6.8; 500 mM DTT; 10% sodium dodecyl 
sulfate (SDS), 0.5% bromophenol blue and 50% glycerol) 
supplemented with protease inhibitor cocktail (1 mM 
phenylmethanesulphonylfluoride and 1 mM sodium 
orthovanadate). After boiling at 100°C for 3 min, equal 
amount of proteins were loaded on 10% polyacrylamide 
gels and separated by electrophoresis. Protein transfer was 
performed on PVDF membrane (Millipore S.p.A. Milan 
Italy). Membranes were blocked with 5% skim milk in 
wash buffer (20 mM Tris-HCl, pH 7.6, 140 mM NaCl, 
0.1% Tween 20) and incubated with the specific primary 
antibodies diluted in blocking solution, at appropriate 
dilutions. Following three washes, membranes were 
incubated with a secondary goat anti-mouse or goat 
anti-rabbit horseradish peroxydase-conjugated antibody 
(BioRad, Hercules, CA, USA) diluted 1:3.000 in wash 
buffer. After three further washes, proteins were revealed 
by chemiluminescence (ECL, Amersham Biosciences AB, 
Uppsala, Sweden) and the signal detected on an X-ray film 
(Amersham Biosciences AB, Uppsala, Sweden). Rabbit 
polyclonal anti-TIMELESS antibody (ab72458) was 
purchased from ABCAM (Cambridge, UK). Mouse anti-
β-Actin antibody (F-3022) was purchased from Sigma-
Aldrich (Milan, Italy). 
Fluorescent in situ hybridization analysis 
Each colorectal cancer cell line was tested by 
fluorescent in situ hybridization (FISH) to detect copy 
number gains of the chromosomal region (12q13.3) 
harboring the TIMELESS gene (chr12:56,810,157-
56,843,200). BAC (Bacterial Artificial Chromosomes) 
clones encompassing both the ~200 kb upstream and 
downstream regions to TIMELESS were selected 
according to the latest release (February 2009, GRCh37/
hg19) of the University of California Santa Cruz (UCSC) 
Human Genome Browser (http://genome.ucsc.edu). 
The probes used were RP11-888B6 (chr12:56,517,568-
56,727,528), RP11-348M3 (chr12:56,684,981-56,848,839) 
and RP11-243C3 (chr12: 56,872,287-57,047,110) 
(Figure 6A). Metaphase spreads were prepared as 
previously described [53] and FISH experiments were 
carried out as reported elsewhere [54]. Briefly, 600 ng of 
each probe were directly labeled with Cy3-, Cy5-, or FITC-
conjugated dUTP by nick translation. Hybridization was 
performed at 37°C in 2X saline-sodium citrate (SSC), 50% 
(v/v) formamide, 10% (wt/vol) dextran sulfate, 5 μg Cot-1 
DNA (Bethesda Research Laboratories, Gaithersburg, MD, 
USA), and 3 μg sonicated salmon sperm DNA in a volume 
of 10 μl. Three post-hybridization washes were performed 
at 60°C in 0.1XSSC. Chromosomes were identified 
by 4′,6-diamidino-2-phenylindole (DAPI) staining. 
Digital images were obtained using a Leica DMRXA 
epifluorescence microscope equipped with a cooled CCD 
camera (Princeton Instruments, Boston, MA, USA). Cy3 
(red; New England Nuclear, Boston, MA, USA), FITC 
(green; Fermentas Life Sciences, Milan, Italy), Cy5 (IR; 
New England Nuclear), and DAPI (blue) fluorescence 
signals, were detected using specific filters, and recorded 
separately as gray-scale images. Pseudocoloring and 
images merging were performed by use of Adobe 
Photoshop software (Adobe Systems, Seattle, WA).
Computational prediction of miR-139-5p seed 
regions on TIMELESS mRNA
Putative miR-139-5p binding sites in TIMELESS 
mRNA were predicted by the RNAHybrid (http://bibiserv.
techfak.uni-bielefeld.de/rnahybrid/) [55] and RNA22 
algorithms (https://cm.jefferson.edu/rna22/) [56] using the 
mature miRNA sequence reported in miRbase v.21 and the 
TIMELESS mature mRNA sequence found on RefSeq ad 
using default settings in both cases. 
Cell transfection assays
CaCo2, HCT116, HT29, SW480 and SW620 cells 
at 70–80% confluence were transiently transfected with 
synthetic miR-139–5p mimic (MSY0000250, QIAGEN) 
or miR-139-5p inhibitor (MIN0000250, QIAGEN) or 
the appropriate scrambled controls (AllStar or mirScript 
Inhibitor-Negative Control) using HiPerfect Transfection 
Reagent (QIAGEN; Hilden, Germany), following the 
manufacturer’s instructions. Transfection efficiency was 
estimated by qRT-PCR evaluating miR-139-5p vs RNU6B 
expression levels. 
Cell proliferation assay 
Cell number and density of viable cells were 
determined using CAsy Cell Counter (Innovatis, 
Sittingbourne, UK) as previously reported [57]. Briefly, 
each sample (cell suspension) was prepared three times 
in CAsyTon (Innovatis) buffer, followed by triplicate 
measurements of 200 μl sample volume. Viable cells 
were measured by Casy Cell Counter by excluding all 
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counts that were of a size smaller that 10 μm (dead cells 
and debris). Three biological replicates were prepared 
and each assayed in triplicate and the results expressed as 
mean ± standard deviation (SD). 
Apoptosis assay
Apoptosis assay was performed as previously 
reported [58] CaCo2, SW480 and SW620 cells were 
transfected with miR-139-5p mimic or inhibitor or 
Controls 48 h at 37°C. Apoptosis was evaluated by 
AnnexinV-FITC and Propidium Iodide stained cells using 
Apoptosis Detection Kit (BD Biosciences), according to 
the manufacturer’s protocols. All flow cytometry results 
were analyzed with FACSuite Software v.1.0.5.3841 (BD 
Biosciences). Three biological replicates were prepared 
and each assayed in triplicate and the results expressed as 
mean ± standard deviation (SD). 
Cell migration and colony forming assay 
Cell migration and colony forming assay were 
performed as previously reported [59]. Briefly, to 
perform the plate colony–forming assay, 24 hours after 
transfection, cells were trypsinized and seeded in six-
well plates (5 × 103 cells); after 7 days, cells were fixed, 
stained and photographed under microscope. The area of 
single colonies was then measured by ImageJ software 
(National Institutes of Health Image, http://rsbweb.nih.gov/
nih-image). We also performed Transwell cell migration 
assay. Briefly, cells after 24 h transfection were trypsinized 
and adjusted to 8 × 105 cells/ml of cell suspension. Cells 
in a 200-µl volume were seeded into the upper chamber 
of Transwell, and added 800 µl medium with 20% FBS 
in the lower chamber. Cells were then cultured at 37°C 
for 48 h and the cells on the surface of the up chamber 
were swapped with cotton swap and the cells under the 
surface of the low chamber were stained with crystal violet 
(0.1%). Cells were then photographed under an inverted 
microscope for capturing pictures and counted for migrated 
cell numbers. Three biological replicates were prepared and 
the results expressed as mean ± standard deviation (SD).
Statistical analysis 
Raw signals of probes were background corrected, 
log-transformed to achieve normal distribution and 
then normalized using the RMA algorithm. Differential 
expression between samples was assessed by paired 
t-test. A miRNA was considered differentially expressed 
if its fold-change of expression was significantly greater 
than 1.5 or lower than −1.5. Correlation of expression 
was measured by Pearson Product Moment Correlation 
(PPMC) and the Pearson correlation coefficient r for all 
the probesets of tumor and non-tumor tissue. Only the 
pairs of human probesets with r significantly greater than 
0.8 or lower than −0.8, were taken into account for the 
subsequent analysis steps. Associations between gene 
expression level and phenotypic characteristics were 
evaluated by the Pearson’s chi-squared test. Survival rates 
were calculated by the Kaplan–Meier method for analysis 
of censored data. Subgroup analyses were performed after 
splitting the subjects into high/low expressing, based on 
the median value of the gene of interest. A p-value < 
0.05 was considered statistically significant. All analyses 
were performed using the SPSS v17 Statistical Package 
(SPSS, Chicago, IL, USA), the R framework and Partek 
Genomics Suite 6.6 (Partek Inc., St. Louis, MO, USA).
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